Vascular aspects in the pathophysiology of glaucomatous optic neuropathy

Citation
Hs. Chung et al., Vascular aspects in the pathophysiology of glaucomatous optic neuropathy, SURV OPHTHA, 43, 1999, pp. S43-S50
Citations number
64
Categorie Soggetti
Optalmology
Journal title
SURVEY OF OPHTHALMOLOGY
ISSN journal
00396257 → ACNP
Volume
43
Year of publication
1999
Supplement
1
Pages
S43 - S50
Database
ISI
SICI code
0039-6257(199906)43:<S43:VAITPO>2.0.ZU;2-6
Abstract
Glaucoma remains a major eye illness with unknown etiology.;Although elevat ed intraocular pressure is clearly a major risk factor, vascular deficits m ay contribute to initiation and progression of glaucoma. When intraocular p ressure is acutely elevated in healthy individuals, the resistance index (d erived from the peak systolic and end-diastolic velocities and an indirect index of vascular resistance distal to the site of measurement) in the cent ral retinal and posterior ciliary arteries increases progressively. This re sult implies that mechanical and vascular factors may be coupled in such a way that perfusion of the retina and optic nerve head may be influenced by changes in the intraocular pressure. Further, at night, when ophthalmic art ery flow velocities fall as arterial blood pressure falls in glaucoma patie nts, the risk of disease progression may be increased. The constancy of the se same flow velocities in age-matched healthy individuals points to a poss ible vascular autoregulatory defect in glaucoma. In addition, in normal-ten sion glaucoma, vasodilation (CO, inhalation) normalizes retrobulbar arteria l flow velocities, hinting that some vascular deficits in glaucoma may be r eversible. Finally, Ca2+ channel blockade improves contrast sensitivity in patients with normal-tension glaucoma, who also show increased retrobulbar vessel flow velocities, a result suggesting that visual function loss may b e linked to ocular ischemia. Emerging evidence points to a role of ischemia in the pathogenesis of glaucoma, suggesting that treatments designed to im prove ocular blood flow may benefit glaucoma patients. (C) 1999 by Elsevier Science Inc. All rights reserved.